Cargando…
Chemical Chaperone and Inhibitor Discovery: Potential Treatments for Protein Conformational Diseases
Protein misfolding and aggregation cause a large number of neurodegenerative diseases in humans due to (i) gain of function as observed in Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, and Prion’s disease or (ii) loss of function as observed in cystic fibrosis and α1-antitrypsin de...
Autores principales: | Zhao, Jian-Hua, Liu, Hsuan-Liang, Lin, Hsin-Yi, Huang, Chih-Hung, Fang, Hsu-Wei, Chen, Shiao-Shing, Ho, Yih, Tsai, Wei-Bor, Chen, Wen-Yih |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754919/ https://www.ncbi.nlm.nih.gov/pubmed/19812735 |
Ejemplares similares
-
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
por: Lu, Shin-Hua, et al.
Publicado: (2011) -
The unhappy chaperone
por: Linse, Sara, et al.
Publicado: (2021) -
Predicting Future Prospects of Aptamers in Field-Effect Transistor Biosensors
por: Vu, Cao-An, et al.
Publicado: (2020) -
The neuroprotective potential of endoplasmic reticulum chaperones
por: McLaughlin, Todd, et al.
Publicado: (2015) -
The aqueous extract of Glycyrrhiza inflata can upregulate unfolded protein response-mediated chaperones to reduce tau misfolding in cell models of Alzheimer’s disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2016)